Se ha denunciado esta presentación.
Utilizamos tu perfil de LinkedIn y tus datos de actividad para personalizar los anuncios y mostrarte publicidad más relevante. Puedes cambiar tus preferencias de publicidad en cualquier momento.

APRIL 2021 ONCOLOGY CARTOONS

APRIL 2021 ONCOLOGY CARTOONS

  • Sé el primero en comentar

APRIL 2021 ONCOLOGY CARTOONS

  1. 1. DR KANHU CHARAN PATRO M.D, D.N.B[RT], FAROI, MBA, PDCR, CEPC APRIL 2021 ISSUE/61st VOLUME FACE BOOK PAGE ONCOLOGY CARTOON PHOTOS CHAPTER WISE
  2. 2. THE MAIN ONCOLOGY JOURNALS 16th MARCH 2021/HISTORY WIKI AROI Dr Kishore Singh Impact factor-0.791 ESTRO Michael Baumann Impact Factor:4.856 ASCO Jonathan W. Friedberg Impact Factor: 32.956 LANCET GROUP David Collingridge Impact Factor: 33.752 ASTRO JAMES D. COX Impact Factor: 5.859 J. E. Tepper Impact Factor: 4.076 ABS Michael Zelefsky Impact Factor: 1.853 IBS/PBS Adam Chicheł Impact Factor: 1.627
  3. 3. SOME RADIOTHERAPY DISCOVERIES & INVENTIONS 17th MARCH 2020/HISTORY Joel E. Gray/Radiology/2000
  4. 4. KNOW YOUR ONCOLOGY AUTHORS 19th MARCH 2021/HISTORY WIKI AROI Dr Kishore Singh Impact factor-0.791 ESTRO Michael Baumann Impact Factor:4.856 LANCET GROUP David Collingridge Impact Factor: 33.752 ASTRO JAMES D. COX Impact Factor: 5.859 ABS Michael Zelefsky Impact Factor: 1.853 IBS/PBS Adam Chicheł Impact Factor: 1.627 Eric J. Hall Faiz M Khan Carlos A. Perez Vincent T. DeVita, Jr,
  5. 5. IMPORTANT ICRU REPORTS 20th MARCH 2021/PHYSICS ICRU WEB SITE ICRU 29 Dose Specification for. Reporting External Beam. Therapy with Photons & Electrons ICRU 38 Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology ICRU 50 Prescribing, Recording, and Reporting Photon Beam Therapy ICRU 58 Dose and Volume Specification for Reporting Interstitial Therapy ICRU 60 Fundamental Quantities and Units for Ionizing Radiation ICRU 62 Prescribing, Recording and Reporting Photon Beam Therapy Supplement to ICRU 50 ICRU 71 Prescribing, Recording, and Reporting Electron Beam Therapy ICRU 78 Prescribing, Recording, and Reporting Proton-Beam Therapy ICRU 83 Prescribing, Recording, and Reporting (IMRT) ICRU 89 Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix ICRU 91 Prescribing, Recording, and Reporting of Stereotactic Treatments LATEST ICRU 95 Operational Quantities for External Radiation Exposure
  6. 6. THE MAIN ONCOLOGY HOSPITALS USA 21st MARCH 2021/HISTORY WIKI MD Anderson Cancer Center (Texas) Mayo Clinic (Rochester, Minn.) MSKCC (New York City) Massachusetts hospital (Boston) Moffitt cancer center (Florida)
  7. 7. THE MAIN ONCOLOGY HOSPITALS EUROPE 22nd MARCH 2021/HISTORY WIKI CHRISTIE HOSPITAL (Manchester) Institut Gustave Roussy Villejuif, France Netherlands Cancer Institute Amsterdam, Netherlands German Cancer Research Center Heidelberg Clatterbridge cancer centre Bebington & Liverpool
  8. 8. KNOW YOUR ONCOLOGY RESEARCH GROUPS 23rd MARCH 2021/HISTORY WIKI ASTRO American Society for Radiation Oncology ESTRO European Society for Radiotherapy & Oncology RTOG Radiation Therapy Oncology Group ASCO American Society of Clinical Oncology ABS American Brachytherapy Society GOG Gynecologic Oncology Group NSABP National Surgical Adjuvant Breast and Bowel Project TROG Trans Tasman Radiation Oncology Group EORTC European Organization for Research and Treatment of Cancer ESMO European Society for Medical Oncology FIGO International Federation of Gynecology and Obstetrics AROI Association of Radiation oncologists' of India ICON Indian Cooperative Oncology Network ISNO Indian Society of Neuro-Oncology COG Children Oncology Group POG Paedriatic Oncology Group IASLC International Association for the Study of Lung Cancer ILROG International Lymphoma Radiation Oncology Group WFNOS World Federation of Neuro-Oncology Societies COGNo The Cooperative Trials Group for Neuro-Oncology NRG NSABP + RTOG + GOG SIOP International Society of Paediatric Oncology ECOG Eastern Cooperative Oncology Group MRC Medical Research Council ISEH Society for Hematology and Stem Cells MSTS Musculoskeletal Tumor Society AHNS American Head and Neck Society BIG Breast International Group NCI National Cancer Institute ISRS International Stereotactic Radiosurgery Society AAPM American Association of Physicists in Medicine ICRU International Commission on Radiation Units & Measurements ICRP International Commission on Radiological Protection RSS The Radiosurgery Society IAEA International Atomic Energy Agency AERB Atomic Energy Regulatory Board EANO European Association of Neuro-Oncology IRSA International Radiosurgery Association IBS Indian Brachytherapy Society SWOG Southwest Oncology Group
  9. 9. KNOW YOUR ONCOLOGY GUIDELINE GROUPS 24th MARCH 2021/HISTORY WIKI GROUP FULL FORM ABOUT LINK ASTRO AMERICAN SOCIETY FOR RADIATION ONCOLOGY RADIOTHERAPY https://www.astro.org/Patient-Care-and- Research/Clinical-Practice-Statements ESTRO EUROPEAN SOCIETY FOR RADIOTHERAPY & ONCOLOGY RADIOTHERAPY https://www.estro.org/Science/Guidelines RTOG RADIATION THERAPY ONCOLOGY GROUP RADIOTHERAPY https://www.rtog.org/ ASCO AMERICAN SOCIETY OF CLINICAL ONCOLOGY ONCOLOGY https://www.asco.org/ ABS AMERICAN BRACHYTHERAPY SOCIETY BRACHYTHERAPY https://www.americanbrachytherapy.org/ NCCN NATIONAL COMPRESSIVE CANCER NETWORK ONCOLOGY https://www.nccn.org/professionals/physician_ gls/default.aspx#site TROG TRANS TASMAN RADIATION ONCOLOGY GROUP RADIOTHERAPY https://www.trog.com.au/ ESMO EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY ONCOLOGY https://www.esmo.org/guidelines ISNO INDIAN SOCIETY OF NEURO-ONCOLOGY BRAIN TUMORS http://isno.in/ ILROG INTERNATIONAL LYMPHOMA RADIATION ONCOLOGY GROUP LYMPHOMA https://www.ilrog.org/ NICE NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE ONCOLOGY https://www.nice.org.uk/guidance/conditions- and-diseases/cancer DEGRO ARBEITSGRUPPE RADIOCHIRURJI/STEREOTAXIE RADIOTHERAPY https://www.degro.org/ag-stereotaxie/practice- guidelines-of-the-degro-working-group- stereotactic-radiotherapy-radiosurgery/
  10. 10. DR SUBIR NAG 25th MARCH 2021/HISTORY WIKI • Dr. Subir Nag, MD is a radiation oncology specialist in Santa Clara, CA. • Dr. Nag completed a residency at Montefiore Medical Center - Moses Division. • He currently practices at Kaiser Santa Clara Cancer Treatment Center and is affiliated with Kaiser Permanente Santa Clara Medical Center. • He authored the principles and practice of brachytherapy book. • Credited with may articles on brachytherapy in various journals • Radiation oncology from AIIMS Delhi alumni
  11. 11. PROF B D GUPTA 26th MARCH 2021/HISTORY B K MOHANTI/JCRT/2018 • Prof BD Gupta was born in Uttar Pradesh on March 8, 1934. After graduating from Medical College, Agra, he did his post graduation in radiology (combined radio- diagnosis and radiotherapy) under Dr PK Haldar. • He obtained the FRCR degree from London and returned to India to exclusively practice radiotherapy and oncology • BD Gupta died in his sleep in his home at Panchkula, on the outskirt of Chandigarh, on the night of September 17, 2017 • He was a founder member of Association of Radiation Oncologists of India, Atomic Energy Regulatory Board, and the National Cancer Control Program (NCCP), India
  12. 12. Professor Minesh Mehta 27th MARCH 2021/HISTORY WIKI • Professor Minesh P Mehta, MD, FASTRO, is an American radiation oncologist and physician- scientist of Indian origin, Ugandan birth, Zambian Schooling and American Training, who contributed to the field of oncology for more than two and half decades • A well-respected clinician and researcher, Dr. Mehta has over a thousand publications, including medical journal manuscripts, book chapters, and professional abstracts, and serves on the editorial board of several peer-reviewed journals. • Additionally, through his work in the RTOG and other clinical trial mechanisms he was instrumental in setting new standards in clinical research on Brain Metastases through a series of well-conducted multicenter, international, randomized trials, incorporating both traditional and novel endpoints, resulting in the most robust neurologic and neurocognitive dataset collection and evaluation for this condition
  13. 13. PROF. MICHAEL BRADA 28th MARCH 2021/HISTORY Google • Professor Brada was the President of ESTRO (2003-2005) and President of EANO (European Association of Neuro-oncology) nurtured a young organisation towards the principal European force it is now. • He has been a leader in the development of radiotherapy in neuro-oncology, with benchmark studies of technical aspects and clinical outcome of stereotactic radiotherapy and key studies of late toxicity of cranial irradiation. • He has also made a major contribution to chemotherapy and radiotherapy in glial tumours and brain metastases. • In lung cancer he developed and tested novel technologies including motion management techniques and high precision irradiation. • Throughout his career has been a passionate believer in evidence based medicine
  14. 14. Guideline on Diet and Physical Activity for Cancer Prevention 29th March 2021/PREVENTION Cheryl L. Rock/ CA CANCER J CLIN 2020
  15. 15. RISK FACTORS FOR BRAIN METASTASIS IN BREAST CANCER 30th March 2021/BREAST Bernardo Cacho-Díaz/CANCER /2020 Look at p value and analyze
  16. 16. STEMMER'S SIGN IN POST OP LYMPHEDEMA 31st MARCH 2021/BREAST Google- Courtesy –Dr Priyasha 1. Stemmer's Sign, a thickened skin fold at the base of the second toe or second finger that is a diagnostic sign for lymphedema. 2. Stemmer Sign is positive when this tissue cannot be lifted but can only be grasped as a lump of tissue; it is negative when it is possible to lift the tissue normally
  17. 17. A. Pseudo‐chilblains lesions on toes of a 17‐year‐old patient. B. Erythemato‐purpuric macules with undefined limits on the heel of a COVID‐19 suspected patient. C. Palpable purpura lesions on the lower extremities of a patient with COVID‐19 pneumonia. D. Polymorphic papulovesicular eruption on a patient presenting simultaneously with palpable purpura on the lower extremities. E. Targetoid lesions at a delayed phase of COVID‐19 pneumonia. F. Maculopapular exanthem on a patient recovered from pneumonia; RT‐PCR test persisted positive. DERMATOLOGICAL MANIFESTATION OF COVID-19 Jour. of Euro.Academy of Dermato & Venereology, /June 2020 1st APRIL 2021/COVID
  18. 18. BRAIN METASTASIS CAVITY DYNAMICS- WHEN TO START SRS? Majed Alghamdi/ Jour. of Radiosurgery and SBRT/2018 2nd APRIL 2021/STEREOTAXY Caution must be taken when treating cavities in the early(<21 days) interval after surgery as it may lead to irradiating more normal tissue especially in small tumors
  19. 19. OPTIC NERVE SHEATH MENINGIOMA RT GUIDELINE Jeffrey V./PRO/2013 3rd APRIL 2021/BRAIN
  20. 20. SABR-COMET STUDY- LONG TERM RESULTS David A. Palma/JCO/2020 1. Between 2012 and 2016, 99 patients were randomly assigned at 10 centers internationally. 2. The most common primary tumor types were breast (n =18), lung (n =18), colorectal (n = 18), and prostate (n = 16). 3. Median follow-up was 51 months. 4. The 5-yr OS rate was 17.7% in pall arm versus 42.3% in SABR arm ( P= .006). 5. The 5-year PFS rate was not reached in pall arm(3.2%; 95% CI, 0% to 14% at 4 years with last patient censored) and 17.3% in SABR arm P .001). 6. There were no new grade 2-5 adverse events and no differences in QOL between arms. 4th APRIL 2021/HCC
  21. 21. RADIOLOGY OF BUCCAL SPACE Google 5th APR 2021/RADIOLOGY The boundaries 1. The angle of the mouth anteriorly 2. The masseter muscle posteriorly 3. The zygomatic process of the maxilla and the zygomaticus muscles superiorly, 4. The depressor anguli oris muscle and the attachment of the deep fascia to the mandible inferiorly, 5. The buccinator muscle medially (the buccal space is superficial to the buccinator) 6. The platysma muscle, subcutaneous tissue and skin laterally (the space is deep to platysma) Content 1. The buccal fat pad 2. The parotid duct (stenson's duct) 3. The anterior facial artery and vein 4. The transverse facial artery and vein
  22. 22. RADIOLOGY OF PARAPHARYNGEAL SPACE 6th APRIL 2021/RADIOLOGY Google
  23. 23. RADIOLOGY OF RETROSTYLOID SPACE 7th APR 2021/RADIOLOGY Google
  24. 24. RADIOLOGY OF PAROTID SPACE 8th APR 2021/RADIOLOGY Google Contents 1. Parotid Glands 2. Intraparotid Lymph Nodes 3. Intraparotid Facial Nerve 4. External Carotid Artery 5. Retromandibular Vein Boundaries 1. Medially: the parapharyngeal space 2. Laterally: superficial space and subcutaneous tissue 3. Posteriorly: the carotid space ▪ Posterior belly of the digastric muscle forms a variable portion of the posteromedial border of the parotid space and separate the parotid space lesion from the carotid space 4. Anteriorly: masticator space 5. Superiorly: external auditory canal; apex of the mastoid process 6. Inferiorly: inferior mandibular margin (although the parotid tail can extend further inferiorly below the angle of the mandible)
  25. 25. SRS DOSES FOR BRAIN LESIONS BOOK-CLINICAL APPLICATION OF SRS AND SBRT 9th APR 2021/STEREOTAXY
  26. 26. TARGET IN SEMINOMA TESTIS WITH SCROTAL VIOLATION Richard B. Wilder/2012/IJROBP 10th APR 2021/TESTIS 1. Radiotherapy directed to the para- aortic nodes alone is not sufficient in patients with a history of pelvic or scrotal surgery because the pattern of primary lymphatic drainage has been altered and may no longer be confined to the para-aortic region. 2. In these cases, inclusion of ipsilateral iliac and inguinal nodes in classic dog- leg AP-PA fields is indicated 3. Prophylactic irradiation of the contra lateral iliac, inguinal, or scrotal region for prior maldescensus testis, inguinal or scrotal violation, or pT3/4 primary tumors is not indicated. 4. Avoid testicular FNAC/BIOPSY and SURGERY in suspected testicular mass
  27. 27. RADIATION DOSE SEMINOMA-IA/IB/IS Jones WG/2005/JCO 11th APR 2021/TESTIS 1. Medical Research Council Trial TE18 showed that 20Gy in 10 daily 2.0Gy fractions is not inferior to 30Gy in 15 daily 2.0Gy fractions . 2. 625 patients were randomly assigned to treatment 3. Like 25.5Gy in 15 daily 1.7Gy fractions over 3 weeks, 20Gy in 10 daily 2.0-Gy fractions over 2 weeks results in excellent survival and freedom from relapse. 4. In conclusion, this study has shown that, compared with 30Gy given in 15 fractions during 3 weeks, 20Gy given in 10 fractions during 2 wks produces excellent results, with less inconvenience to the patient in terms of the numbers of hospital visits and severity of adverse effects, allowing a speedier resumption of normal living.
  28. 28. FIELD AND DOSE IN SEMINOMA IA or IB Richard B. Wilder/2012/IJROBP 12th APR 2021/TESTIS 1. Patients with no history of pelvic or scrotal surgery before inguinal orchiectomy have traditionally been treated with opposed AP-PA fields from the top of the T11 vertebral body to the bottom of the L5 vertebral body. 2. Para-aortic fields based on bony anatomy are approximately 9 to11 cm wide. 3. Lateral borders have traditionally been placed at the tips of the transverse processes. 4. Several groups advocate inclusion of the left renal hilum in AP-PA fields for left sided testicular seminoma. 5. Left renal hilar nodes are commonly included in AP-PA fields when the left lateral border is placed at the most lateral tips of the transverse processes of the T12-L5 vertebrae. 6. Typically, the L5 vertebra has transverse processes that extend the farthest laterally. 7. Nodal mapping studies suggest that inclusion of left renal hilar nodes in a nodal CTV may be optional in a patient with a relatively lateral left kidney
  29. 29. FIELD AND DOSE IN SEMINOMA IIA or IIB 13th APR 2021/TESTIS Clinical Stage IIA or IIB 1. UPPER BORDER- 2CM BELOW KIDNEY 2. LOWER BOREDR –UPPER BORDER ACETABULUM 3. LATERAL BORDER- for the lower part of modified dog-leg fields is defined by a line from the tip of the ipsilateral transverse process of the fifth lumbar vertebra to the superolateral border of the ipsilateral Acetabulum 4. MEDIAL BORDER -May be drawn from the tip of the contra lateral transverse process of the fifth lumbar vertebra toward the medial border of the ipsilateral obturator foramen. 5. BOOST-2-cm margin on the retroperitoneal adenopathy 6. PTV1-20Gy/10FRACTION 7. PTV2 BOOST- 10 Gy in 5 fractions over for clinical Stage IIA disease and 16 Gy in 8 fractions Richard B. Wilder/2012/IJROBP
  30. 30. PA NODE IN SEMINOMA TESTIS BASED ON CTV Richard B. Wilder/2012/IJROBP 14th APR 2021/TESTIS 1. Nodal CTV should include the paracaval, precaval, and interaortocaval lymph nodes for right-sided testicular seminomas and at least the lateroaortic and preaortic lymph nodes for left-sided testicular seminomas. 2. Others have suggested inclusion of similar lymph node groups in a nodal CTV . 3. One should contour the inferior vena cava and aorta separately from 2 cm below the top of the kidneys down to the point where these blood vessels end. 4. One may provide a 1.2-cm expansion on the inferior vena cava and a larger, 1.9cm expansion on the aorta to include the Later-aortic nodes, thereby creating a nodal CTV1. 5. Bone and bowel should be excluded from CTV1. 6. A uniform 0.5-cm margin should be provided on CTV1 to create a planning target volume (PTV1) that accounts for treatment setup errors
  31. 31. ABCDE APPROACH FOR LIFESTYLE MODIFICATION A FOR AWARENESS B FOR BP CONTROL C FOR CIGARETTE STOP D FOR DIABETES CONTROL AND DIET MODIFICATION GOOGLE 15th APR 2021/PUBLIC

×